Hofmeister Robert 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 23, 2020
Insider Transaction Report
Form 4
Hofmeister Robert
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2020-12-22$0.74/sh+7,000$5,180→ 45,850 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-22−7,000→ 28,732 totalExercise: $0.74Exp: 2026-12-13→ Common Stock (7,000 underlying)
Footnotes (2)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]25% of this option shall vest and become exercisable on December 13, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.